Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Crl
  6. /
  7. ACCORD BIOPHARMA INC
CRL
•ACCORD BIOPHARMA INC

ACCORD BIOPHARMA INC – FDA CRL

Record Details

The U.S. Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) to Accord BioPharma Inc. regarding its Biologics License Application (BLA 761027) for INTP1. The FDA determined that the application cannot be approved in its current form due to several outstanding issues. A primary concern stems from unresolved deficiencies identified during recent inspections of the drug substance and drug product manufacturing facilities, as outlined in FDA Form 483. The company must provide satisfactory responses to these findings for the application to be reconsidered, potentially necessitating a re-inspection.

Furthermore, the FDA has reserved comments on the proposed prescribing information, carton, and container labeling until all other application deficiencies are adequately addressed. The proposed proprietary name was conditionally acceptable but requires resubmission once all issues are resolved.

A significant requirement involves a comprehensive safety update. Accord BioPharma must detail any changes in the safety profile, incorporate new clinical safety data, retabulate adverse events and study discontinuations, and provide case report forms for deaths or serious adverse events. This update also mandates inclusion of updated exposure information, a summary of worldwide safety experience, and English translations of any current foreign labeling.

Under 21 CFR 601.3(b), Accord BioPharma is required to resubmit the application, fully addressing all identified deficiencies, or take other actions within one year to avoid potential withdrawal under 21 CFR 601.3(c). The company may request a meeting to discuss the necessary steps before the product can be legally marketed.

Company
ACCORD BIOPHARMA INC
Product type
BLA
Person
  • Sabita Nair, RAC, ASQ-CPGP
View Company Profile

ID · 393e22bb-be87-465f-ab1a-e90a7fa5a512

Other documents for ACCORD BIOPHARMA INC
  • CRL
  • CRL
  • CRL
  • CRL

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore ACCORD BIOPHARMA INC
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.